ID
25307
Descripción
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Palabras clave
Versiones (5)
- 31/8/17 31/8/17 -
- 31/8/17 31/8/17 -
- 4/9/17 4/9/17 -
- 4/9/17 4/9/17 -
- 11/9/17 11/9/17 -
Subido en
31 de agosto de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
Similar models
drug screening and alcohol test - compare the PK and tolerability of ropinirole administered as 5 new formulations with the standard, marketed formulation 101468/197
C0456984 (UMLS CUI [1,2])
C0456984 (UMLS CUI [1,2])
C0202306 (UMLS CUI [1,2])